It's like any speculative stock. A company has a thesis that it...

It's like any speculative stock. A company has a thesis that it starts planning to eother confirm or reject. The reality vs the dream get realised at different stages to different participants. A stock that keeps delivering - in ir1's case, the assays need to correlate with the the pegmatie visuals. Any variation to the downside and this will be sold down in the short term. Any cobfirmation and it will form a new base whilst waiting for further confirmation. As each layer of proof gets confirmed to continue with tge narrative, so does the support for the stock.
A failure in any can result in significant retracements depending on the extent of the failure. This is always the risk and as u correctly pointed out if one needs less risk, the banking sector is the most comforting. However, let's say iris follows through with the goods, where do u see this opening?